Rx&DAbout Rx&DPharmaceutical CommunityPublicationsMedia Centre
Stakeholders & PartnershipsMember's Login
 
 
 
  Forgot Password?
  Account Application
 
Rx&D HomeFrançaisContact Us
Useful LinksSite Map
  Media Centre

Letters-to-the-Editor/Op-Ed 

  • Letter-to-the-Editor – June 18, 2008
    The Packet and Times (Orillia, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on June 18, 2008 on the PM (NOC) Regulations. Read More

  • Letter-to-the-Editor – June 12, 2008
    The Trail Daily Times (Trail, BC) published a Letter-to-the-Editor by Rx&D President Russell Williams on June 12, 2008 on the PM (NOC) Regulations. Read More

  • Letter-to-the-Editor – June 12, 2008
    The Chronicle-Herald (Halifax, NS) published a Letter-to-the-Editor by Rx&D President Russell Williams on June 12, 2008 on the PM (NOC) Regulations. Read More

  • Letter-to-the-Editor – June 12, 2008
    The Standard (St. Catharines, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on June 12, 2008 on the PM (NOC) Regulations. Read More

  • Letter-to-the-Editor – June 11, 2008
    The Daily Gleaner (Fredericton, NB) published a Letter-to-the-Editor by Rx&D President Russell Williams on June 11, 2008 on the PM (NOC) Regulations. Read More  

  • Letter-to-the-Editor – June 10, 2008
    The Times & Transcript (Moncton, NB) published a Letter-to-the-Editor by Rx&D President Russell Williams on June 10, 2008 on the PM (NOC) Regulations. Read More
     

  • Letter-to-the-Editor – June 10, 2008
    The Telegraph Journal (Saint John, NB) published a Letter-to-the-Editor by Rx&D President Russell Williams on June 10, 2008 on the PM (NOC) Regulations. Read More
     
  • Letter-to-the-Editor – April 23, 2008
    The Sault Star (Sault Ste. Marie, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on April 23, 2008 in response to an article on the value of new medicines and vaccines. Read More
     
  • Letter-to-the-Editor – April 18, 2008
    Le Soleil (Quebec, QC) published a Letter-to-the-Editor by Rx&D President Russell Williams on April 18, 2008 in response to an article on company donations. Read More (document available in French only)
     
  • Letter-to-the-Editor – April 15, 2008
    Le Devoir (Montreal, QC) published a Letter-to-the-Editor by Rx&D President Russell Williams on April 15, 2008 in response to an article on the safety of medicines. Read More (document available in French only)
     
  • Letter-to-the-Editor – March and April 2008
    In March and April 2008, the following papers have published a Letter-to-the-Editor by Rx&D President Russell Williams in response to articles on the Rx&D Code of Conduct. Read More
    The Calgary Herald, The Calgary Sun, The Cornwall Standard-Freeholder, The Edmonton Journal, The Globe and Mail, The Kamloops Daily News, The Montreal Gazette, The Ottawa Citizen, The Owen Sound Sun Times, The Peterborough Examiner, The Sault Star, The St. Catharine’s Standard, The Timmins Daily Press, The Vancouver Sun, The Windsor Star and The Winnipeg Free Press.
     
  • Letter-to-the-Editor – March 1, 2008
    The Daily Gleaner (Fredericton, NB) published a Letter-to-the-Editor by Rx&D President Russell Williams on March 1, 2008 on the value of new medicines and vaccines. Read More
     
  • Letter-to-the-Editor – February 21, 2008
    The Globe and Mail (Toronto, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on February 21, 2008 on the safety of new medicines. Read More
     
  • Letter-to-the-Editor – February 8, 2008
    La Presse (Montreal, QC) published a Letter-to-the-Editor by Rx&D Vice President Jacques Lefebvre on February 8, 2008 in response to an article on the value of new medicines and vaccines. (document available in French only) Read More
     
  • Op-Ed – February 04, 2008
    Rx&D Board Chairman Mr. Ronnie Miller, on the value new medicines and vaccines bring to the Canadian healthcare system (The Hill Times, Ottawa, ON). Read More
     
  • Letter-to-the-Editor - November 15, 2007
    The Ottawa Citizen (Ottawa, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on November 15, 2007 in response to an article on universities accepting corporate funding for research. Read More
     
  • Letter-to-the-Editor - November 13, 2007
    The Globe and Mail (Toronto, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on November 13, 2007 on access to new medicines. Read More
     
  • Letter-to-the-Editor - November 12, 2007
    The Calgary Herald (Calgary, AB) published a Letter-to-the-Editor by Rx&D President Russell Williams on November 12th in response to an article on universities accepting corporate funding for research. Read More
     
  • Letter-to-the-Editor - November 11, 2007
    The Gazette (Montreal, QC) published a Letter-to-the-Editor by Rx&D President Russell Williams on November 11, 2007 in response to an article on universities accepting corporate funding for research. Read More
     
  • Op-Ed - October 22, 2007
    Rx&D President Russell Williams on the Quebec advantage and Rx&D’s commitment to put patients first in The Gazette (Montreal, QC). Read More
       
  • Letter-to-the-Editor - September 24, 2007
    The Globe and Mail (Toronto, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on September 24 in response to an article on Canada’s Access to Medicines Regime (CAMR). Read More
     
  • Letter-to-the-Editor - September 18, 2007
    The Daily Gleaner (Fredericton, NB) published a Letter-to-the-Editor by Rx&D President Russell Williams on September 18 in response to a Letter to the Editor on the high cost of drugs draining health care. Read More
     
  • Letter-to-the-Editor - August 27, 2007
    The Vancouver Province (Vancouver, BC) published a Letter-to-the-Editor by Rx&D President Russell Williams on August 27 in response to an editorial on access to new medicines and vaccines. Read More
     
  • Letter-to-the-Editor - August 20, 2007
    The Toronto Star (Toronto, ON) published a Letter-to-the-Editor by Rx&D President Russell Williams on August 20 in response to an editorial on Canada’s Access to Medicines Regime (CAMR). Read More
     
  • Letter-to-the-Editor - August 18, 2007
    The Abbotsford News (Abbotsford, BC) published a Letter-to-the-Editor by Rx&D President Russell Williams on August 18 in response to The Toronto Star editorial on Canada’s Access to Medicines Regime (CAMR). Read More
     
  • Letter-to-the-Editor - August 17, 2007
    The Record (Sherbrooke, QC) published a Letter-to-the-Editor by Rx&D President Russell Williams on August 17 , 2007 in response to an editorial on the New Zealand model for pharmaceuticals. Read More
     
  • Letter-to-the-Editor - August 17, 2007
    The Times-Colonist (Victoria, BC) published a Letter-to-the-Editor by Rx&D Vice President Jacques Lefebvre on August 17 2007 in response to an article on a University of British Columbia study. Read More
     
  • Letter-to-the-Editor - July 14, 2007
    La Voix de l’Est (Granby, QC) published a Letter-to-the-Editor by Rx&D President Russell Williams on July 14, 2007 regarding La Politique du médicament in Quebec. Read More (document available in French only)
     
  • Letter-to-the-Editor - July 13, 2007
    The Kootenay Western Star of BC published a Letter-to-the-Editor by Rx&D President Russell Williams on July 13, 2007 regarding the cost and value of new medicines. Read More
     
  • Letter-to-the-Editor - May 11, 2007
    The Similkameen Spotlight published a Letter-to-the-Editor by Rx&D President Russell Williams on May 11 regarding the price and value of new medicines. Read More
     
  • Letter-to-the-Editor - May 03, 2007
    The Terrace Standard published a Letter-to-the-Editor by Rx&D President Russell Williams on May 03 regarding the price and value of new medicines. Read More
     
  • Letter-to-the-Editor - January 14, 2007
    The Ottawa Citizen published a Letter-to-the-Editor by Russell Williams on January 14 entitled “Drug firms play significant role in Third World health.” The Letter outlines the industry’s position on CAMR and highlights the ongoing work by innovative pharmaceutical community to improve the health of people in the developing world. Read more
     
 
 
Back to top

Home | About Rx&D | Pharmaceutical Community | Publications | Media Centre | Stakeholders & Partnerships
Useful Links | Français | Contact Us | Site Map

55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Tel.: (613) 236-0455 Reception Fax: (613) 236-6756
Strategic Affairs & Communications Fax: (613) 236-6861
Federal Affairs Fax: (613) 236-7919
© 2007 Rx&D Terms and Conditions of Use
All Rights Reserved